Thermo Fisher Scientific Inc
Thermo Fisher Scientific Inc/ US8835561023 /
TMO
08/11/2024 21:59:58
|
Diferencia
-4.29
|
Volumen |
Bid- |
Ask- |
Capitalización de mecado |
Dividendo A. |
P/E Ratio |
551.65USD
|
-0.77%
|
53,794 Volumen de negocios: 29.75 millones |
-Volumen de oferta: - |
-Tamaño/ Volumen/ Formato de Ask: - |
211.04 mil millonesUSD |
0.25% |
35.55 |
Descripción de negocio
Thermo Fisher Scientific Inc. (NYSE: TMO) is the world leader in serving science. The company's mission is to enable its customers to make the world healthier, cleaner and safer. Thermo Fisher Scientific helps its customers accelerate life sciences research, solve complex analytical challenges, improve patient diagnostics and increase laboratory productivity. Through its premier brands – Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific and Unity Lab Services – the company offers an unmatched combination of innovative technologies, purchasing convenience and comprehensive support.
Consejo de gestión & Consejo de supervisión
CEO |
Marc N. Casper |
Consejo de gestión |
Stephen Williamson, Konrad Bauer, Michael A. Boxer, Lisa P. Britt, Daniella Cramp, David Johnston, Aditya Joshi, Michel Lagarde, Frederick M. Lowery, Jim Meyer, Monica Manotas, Karen E. Nelson, Paul Parker, Gianluca Pettiti, Sandy Pound, Alan Sachs, Mike Shafer, Daniel P. Shine, Mark Smedley, Ryan Snyder, John Sos, Richard Spoor, Sebastian Pacios, Stephen Williamson |
Consejo de supervisión |
Marc N. Casper, C. Martin Harris, Debora L. Spar, Dion J. Weisler, Dr. Tyler Jacks, James C. Mullen, Lars Rebien Sørensen, Nelson J. Chai, R. Alexandra Keith, Ruby R. Chandy, Scott M. Sperling, Jennifer M. Johnson |
Datos de la empresa
Nombre: |
Thermo Fisher Scientific Inc. |
Dirección: |
168 Third Avenue,Waltham, Massachusetts 02451, USA |
Teléfono: |
+1-781-622-1000 |
Fax: |
+1-781-622-1207 |
E-mail: |
info@thermofisher.com
|
Internet: |
www.thermoscientific.com |
Industria: |
Industry |
Sector: |
Industrial, Diversified |
Subsector: |
Industrial, Diversified |
Fin del año financiero: |
31/12 |
Acciones de libre circulación: |
84.13% |
Fecha de OPI: |
01/01/1980 |